Dr. Rohit Dwivedi, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 12361 W Bola Dr Ste 109, Surprise, AZ 85378 Phone: 623-227-1000 Fax: 623-227-2000 |
Dr. Chevon M Rariy, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 14780 W Mountain View Blvd Ste 120, Surprise, AZ 85374 Phone: 623-215-9460 Fax: 623-282-3576 |
News Archive
Dezima Pharma ('Dezima'), the biotechnology company developing innovative drugs in the field of dyslipidemia, announced today the in-licensing of a cholesteryl ester transfer protein (CETP) inhibitor DEZ-001 (formerly TA-8995) from Mitsubishi Tanabe Pharma Corporation (MTPC). Terms of the deal were not disclosed.
USA Today: "Mental health disorders caused more hospitalizations among U.S. troops in 2009 than any other reason according to medical data released recently by the Pentagon. ... Last year was the first in which hospitalizations for mental disorders outpaced those for injuries or pregnancies in the 15 years of tracking by the Pentagon's Medical Surveillance Monthly report."
Today's health policy news coverage helps fill in the details of the much-anticipated rule for accountable care organizations, which was released yesterday by the Obama administration.
An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant Stent Graft System from Medtronic, Inc., delivered strong results through one year of patient follow-up in the company's U.S. pivotal study, according to clinical data presented at VEITHsymposium.
"The Obama administration is expected to continue including science and technology (S&T) in its diplomacy agenda, according to interviews with a number of people recognized for their contributions to international science cooperation," SciDev.Net reports.
› Verified 9 days ago